Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.3400 (1.87%) ($7.3400 - $7.3400) on Fri. Sep. 22, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.28% (three month average) | RSI | 51 | Latest Price | $7.3400(1.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.4% a day on average for past five trading days. | Weekly Trend | BCRX advances 2.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) OIH(66%) XOP(39%) KWEB(35%) XLE(31%) BOTZ(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.64% in a week (0% probabilities). EWI(-63%) SIL(-62%) ARKG(-44%) ICLN(-24%) XLRE(-54%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.64% (StdDev 3.28%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.37(-0.41%) | 10 Day Moving Average | $7.15(2.66%) | 20 Day Moving Average | $7.12(3.09%) | To recent high | -6.9% | To recent low | 9.6% | Market Cap | $1.295b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |